EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study

Barbara Giordani iD, Luigi Pirtoli, Guido Putignano iD, Antonio Giordano iD, Daniela Marotto iD, Giovanni Baglio iD, Onco-Rheumatology Study Group of the CREI Executive Board (Italian College of Rheumatology)

Cancers · 23.03.2026 · 18 (6) · 1027

DOI: 10.3390/cancers18061027 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cancers, online erschienen am 23.03.2026. Verfasst von Barbara Giordani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Italian National Agency for Regional Healthcare Services (AGENAS), 00187 Rome, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer represents a major concern in rheumatology. Epidemiological studies have demonstrated associations between rheumatic conditions and increased cancer risk at specific sites. However, comprehensive Italian epidemiological data on this association remain lacking.

Methods

We conducted a nationwide retrospective cohort study using Italian Hospital Discharge Records from patients hospitalized between 1 January and 31 December 2018, with follow-up until 31 December 2023. Adult patients with Immune-mediated inflammatory diseases (IMID), including rheumatoid arthritis (RA) and diffuse diseases of connective tissue (DDCT), were the exposed group. The unexposed group included patients with primary diagnoses of injury and poisoning, with no IMID history. We used multivariable logistic regression models to assess cancer association, adjusting for demographics, geography, time of follow-up and comorbidities.

Results

We included 54,896 IMID patients (exposed) and 301,126 unexposed. During the five-year follow-up, the IMID group was significantly associated with cancer (adjusted OR 1.32, 95% CI 1.27–1.38; p < 0.001). The ORadj decreased over time, from 1.83 (p < 0.001) in year one to 1.20 (p < 0.001) from the fifth year onward. Significant association with lung cancer (ORadj 1.74; p < 0.001), leukemia and lymphoma (ORadj 1.98; p < 0.001), bladder (ORadj 1.48; p < 0.001) and melanoma (ORadj 1.48; p = 0.009) were observed in the IMID group. DDCT patients showed an overall higher cancer risk (ORadj 1.53, p < 0.001) than RA patients (ORadj 1.20, p < 0.001).

Conclusions

This first nationwide Italian study confirms an association with cancer in IMID patients, with the highest association in the first year post-diagnosis. The temporal decrease in cancer risk generates the hypothesis that inflammation, rather than medication, may be the primary driver. These findings support enhanced cancer surveillance in IMID patients, particularly during the first year after diagnosis.

Schlagwörter

Stichwörter der Autor:innen

Immune-mediated inflammatory diseases (IMID)cancerdiffuse diseases of the connective tissuehospital-based cohort studymalignancyrheumatoid arthritis

Autor:innen und Institutionen

  • Italian National Agency for Regional Healthcare Services (AGENAS), 00187 Rome, Italy.
  • Sbarro Institute, College of Science and Technology's Biotechnology, Temple University, Philadelphia, PA 19122, USA.
  • Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy.
  • bioERGOtech, 74123 Taranto, Italy.
  • Azienda Socio-Sanitaria Locale della Gallura, 07026 Olbia, Italy.

ORCID-Profile: Barbara Giordani, Guido Putignano, Antonio Giordano, Daniela Marotto, Giovanni Baglio

Förderung

  • Italian Ministry of Health

Zitieren

APA

Giordani, B., Pirtoli, L., Putignano, G., Giordano, A., Marotto, D., Baglio, G., & Onco-Rheumatology Study Group of the CREI Executive Board (Italian College of Rheumatology) (2026). Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study. Cancers, 18(6), 1027. https://doi.org/10.3390/cancers18061027

Vancouver

Giordani B, Pirtoli L, Putignano G, Giordano A, Marotto D, Baglio G, et al. Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study. Cancers. 2026;18(6):1027. doi:10.3390/cancers18061027

BibTeX
@article{Giordani2026,
  author = {Giordani, Barbara and Pirtoli, Luigi and Putignano, Guido and Giordano, Antonio and Marotto, Daniela and Baglio, Giovanni and Onco-Rheumatology Study Group of the CREI Executive Board (Italian College of Rheumatology), Onco-Rheumatology Study Group of the CREI Executive Board (Italian College of Rheumatology)},
  title = {Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {1027},
  doi = {10.3390/cancers18061027}
}
Kostenlos starten →